Kyverna Therapeutics, Inc. (KYTX) Tops Q3 EPS by 17c

Kyverna Therapeutics, Inc. (NASDAQ: KYTX) reported Q3 EPS of ($0.85), $0.17 better than the analyst estimate of ($1.02).

For earnings history and earnings-related data on Kyverna Therapeutics, Inc. (KYTX) click here.

You May Also Be Interested In

• AppLovin Corp (APP) PT Lowered to $510 at Evercore ISI, 'Taking a More Cautious Q4/FY27 View'
• Hyperscale Data holds 215 Bitcoin, sells 65 for $5.1M
• Global S&P Futures lower in premarket